BD Announces New Leadership for BD Biosciences
Jun 17, 2019
San Jose, Calif., June 17, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the appointment of Puneet Sarin to worldwide president, BD Biosciences, effective today.
In his new role, Puneet will be responsible for driving the global strategic, operational and commercial performance across BD Biosciences while advancing the innovation pipeline, associate engagement and customer experience for the business.
Prior to joining BD, Puneet was senior vice president & general manager of the Chemistry and Immunoassay business unit at Beckman Coulter, an operating company of Danaher Corporation. Puneet was with Danaher for almost 6 years where he previously held other roles with Beckman Coulter in the Chemistry & Immunoassay and Pathology Imaging business unit (within Leica Biosystems). Before joining Beckman Coulter, Puneet worked for GE where he held roles of increasing leadership and responsibility in their Industrial, Energy and Healthcare divisions. He holds a Bachelor of Science from Milwaukee School of Engineering and a Master of Business Administration from Emory University.
“Puneet Sarin is an established leader in the life sciences and clinical in vitro diagnostics industry with over more than 20 years of experience,” said Patrick Kaltenbach, executive vice president of Life Sciences at BD. “His proven track record in developing high-performing teams, growing businesses and driving innovation makes him an ideal leader for the BD Biosciences business. We are excited to have him join the BD Life Sciences segment.”
About BD Biosciences
BD Biosciences is a leading provider of high-quality flow cytometry and single-cell genomics solutions, scientific research and clinical laboratories. The business develops products that provide a systems-level understanding of the immune system, including high-parameter cell analysis and sorting capabilities, a single-cell multiomics suite and robust analysis software solutions.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
For more information on BD, please visit bd.com.
Back to News Releases